Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients

BACKGROUND: Although immunotherapy has demonstrated similar clinical activities in the treatment of lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC), several studies have shown programmed death-ligand 1 (PD-L1) to have different predictive roles in ADC and SCC. This study was conducted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuo, Qu, Xiujuan, Li, Zhi, Che, Xiaofang, Cao, Lili, Yang, Xianghong, Hu, Xuejun, Xu, Ling, Hou, Kezuo, Fan, Yibo, Wen, Ti, Liu, Yunpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033326/
https://www.ncbi.nlm.nih.gov/pubmed/33842618
http://dx.doi.org/10.21037/atm-20-968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033326/
https://www.ncbi.nlm.nih.gov/pubmed/33842618
http://dx.doi.org/10.21037/atm-20-968

Ejemplares similares